You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
El recorrido que nuestra práctica clínica fue teniendo en estos últimos años fue el producto de cuestionamientos que la misma clínica nos arrojaba. El poder escucharlos e intentar abrir las preguntas sobre aquello que no cerraba con una lineal explicación de alguno de sus aspectos, hizo posible esta construcción. Así, la clínica de los problemas en el lenguaje empezó a arrojar preguntas: ¿Por qué muchos niños con problemas en el lenguaje no pueden jugar? ¿Por qué algunos sonidos de la lengua no ingresan en el sistema que ya posee el niño? ¿Por qué en algunos niños el lenguaje los roza, pero no los toma? Las preguntas fueron muchas, pero una aparece en el centro de la escen...
For several years now, both eHealth applications and digitalization have been seen as fundamental to the new era of health informatics and public health. The current pandemic situation has also highlighted the importance of medical informatics for the scientific process of evidence-based reasoning and decision making at all levels of healthcare. This book presents the accepted full papers, short papers, and poster papers delivered as part of the 31st Medical Informatics in Europe Conference (MIE 2021), held virtually from 29-31 May 2021. MIE 2021 was originally due to be held in Athens, Greece, but due to the continuing pandemic situation, the conference was held as a virtual event. The 261 papers included here are grouped into 7 chapters: biomedical data, tools and methods; supporting care delivery; health and prevention; precision medicine and public health; human factors and citizen centered digital health; ethics, legal and societal aspects; and posters. Providing a state-of-the-art overview of medical informatics from around the world, the book will be of interest to all those working with eHealth applications and digitalization to improve the delivery of healthcare today.
The revised and extended BMW Art Guide by Independent Collectors presents 304 private collections of contemporary art accessible to the public—featuring large and small, famous and the relatively unknown. Succinct portraits of the collections with countless color illustrations take the reader to 51 countries, often to regions or urban districts that are off-the-beaten-path. This practical guide is a collaborative publication stemming from the partnership between BMW and Independent Collectors, the international online platform for collectors of contemporary art. To date, neither the Internet nor any book has ever contained a comparable assembly of international private collections, including several that have opened their doors to art lovers and connoisseurs for the first time.
The revised and expanded BMW Art Guide by Independent Collectors presents 256 private collections of contemporary art accessible to the public—large and small, famous and still undiscovered. Succinct portraits of the collections with countless color illustrations take the reader to more than forty countries, often to regions or urban districts that are off the beaten path. This practical guide is a collaborative publication stemming from the partnership between BMW and Independent Collectors, the international online network for collectors of contemporary art. Collectors, gallerists, artists, and journalists assisted in the extensive research and revision of this unique standard work. To d...
This volume – for pharmacologists, systems biologists, philosophers and historians of medicine – points to investigate new avenues in pharmacology research, by providing a full assessment of the premises underlying a radical shift in the pharmacology paradigm. The pharmaceutical industry is currently facing unparalleled challenges in developing innovative drugs. While drug-developing scientists in the 1990s mostly welcomed the transformation into a target-based approach, two decades of experience shows that this model is failing to boost both drug discovery and efficiency. Selected targets were often not druggable and with poor disease linkage, leading to either high toxicity or poor eff...